Free Trial

Bioqual (OTCMKTS:BIOQ) Shares Down 1.7% - Here's What Happened

Bioqual logo with Medical background

Bioqual, Inc. (OTCMKTS:BIOQ - Get Free Report) dropped 1.7% during trading on Thursday . The company traded as low as $65.00 and last traded at $65.00. 200 shares were traded during trading, a decline of 42% from the average daily volume of 344 shares. The stock had previously closed at $66.10.

Bioqual Price Performance

The stock has a market cap of $58.11 million, a P/E ratio of -52.85 and a beta of -0.34. The company has a fifty day moving average of $67.14 and a 200 day moving average of $69.20.

Bioqual (OTCMKTS:BIOQ - Get Free Report) last posted its quarterly earnings data on Tuesday, October 22nd. The company reported ($0.76) EPS for the quarter. The firm had revenue of $11.77 million during the quarter. Bioqual had a negative return on equity of 2.87% and a negative net margin of 1.99%.

About Bioqual

(Get Free Report)

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bioqual Right Now?

Before you consider Bioqual, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioqual wasn't on the list.

While Bioqual currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Transportation Stocks to Watch in 2025: Top Picks for Growth
Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines